Beschreibung
Bloating and distension outcomes from the synbiotic trial are presented, showing symptom trajectories across study visits.
Figure 11
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 11: Bloating and distension outcomes from the synbiotic trial are presented, showing symptom trajectories across study visits.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Bloating and distension outcomes from the synbiotic trial are presented, showing symptom trajectories across study visits." /> <figcaption>Figure 11. Bloating and distension outcomes from the synbiotic trial are presented, showing symptom trajectories across study visits.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
Verwandte Evidenz
B
Bifidobacterium longum für Irritable Bowel Syndrome (IBS)
B
Bewertung B · 4 Studien
Galactooligosaccharides (GOS) für Irritable Bowel Syndrome (IBS)
B
Bewertung B · 3 Studien
Lactobacillus acidophilus für Irritable Bowel Syndrome (IBS)
D
Bewertung B · 3 Studien
Fructooligosaccharides (FOS) für Irritable Bowel Syndrome (IBS)
Bewertung D · 2 Studien